Article
Genetic and epigenetic determinants of B-cell lymphoma evolution.
Current opinion in hematology - 1 Jul 2016
Izzo Franco, Landau Dan A
Abstract excerpt
PURPOSE OF REVIEW: The success of targeted therapies fostered the development of increasingly specific and effective therapeutics for B-cell malignancies. However, cancer plasticity facilitates disease relapse, whereby intratumoral heterogeneity fuels tumor evolution into a more aggressive and resistant form. Understanding cancer heterogeneity and the evolutionary processes underlying disease relapse is key for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
